Oxular’s CSO, Ron Yamamoto, shared an overview of Oxular’s drug delivery formulations at the OIS Drug Delivery meeting.
You can watch the entire talk below, to find out more about our long-lasting drug formulations – including a first look at our micelle technology designed for targeted, local delivery of chemotherapeutic agents in the suprachoroidal space.